Skip to main content
07/04/2020 - 13:23

Zelira shares soar on marijuana trial

07/04/2020 - 13:23

Bookmark

Save articles for future reference.

Zelira Therapeutics shares have surged more than 25 per cent after a clinical trial showed its medical marijuana drug candidate successfully treated chronic insomnia.

X

To read our articles you will need to either login or subscribe.